{'fraction_non_alphanumeric': 0.033482142857142856, 'fraction_numerical': 0.008928571428571428, 'mean_word_length': 5.803030303030303, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Tricuspid endocarditis with pulmonary emboli.

Right-sided endocarditis accounts for 5–10% of all cases of infective endocarditis.1 Its epidemiology, diagnosis, and treatment differ from that of left-sided endocarditis, making it a distinct entity. This article presents a case of tricuspid valve endocarditis in an intravenous drug user, and discusses the presentation, diagnosis, and therapeutic considerations unique to right-sided endocarditis.